Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001044321-11-000026
Filing Date
2011-01-21
Accepted
2011-01-21 16:42:40
Documents
1
Period of Report
2010-12-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 4193
  Complete submission text file 0001044321-11-000026.txt   6259
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Reporting) CIK: 0001044321 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-29173 | Film No.: 11541757

Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617 674 5300
VERENIUM CORP (Issuer) CIK: 0001049210 (see all company filings)

EIN.: 223297375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals